BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  SoCal’s Hancock Jaffe Laboratories Files for $20M IPO

  The firm is developing life-enhancing bioprosthetic devices and technologies for patients with debilitating cardiovascular diseases.

  December 8, 2017

   · 

  1 min read
• 

  Policy

  SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission

  No clinical trials are required for the NDA resubmission.

  December 8, 2017

   · 

  4 min read
• Pharm Country

  OraSure Technologies Announces 2018 Annual Meeting Date

  Further details regarding the meeting will be provided at a later date.

  December 8, 2017

   · 

  1 min read
• Drug Development

  Radius Investigational Drug Elacestrant (RAD1901) Continues to Show Promise in Advanced ER+ / HER2- Breast Cancer at the 2017 San Antonio Breast Cancer Symposium

  Elacestrant recently received Fast Track designation from the U.S. Food and Drug Administration.

  December 8, 2017

   · 

  7 min read
• Biotech Beach

  Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock

  The quarterly dividend on the Series E Preferred Stock is payable on January 2, 2018 to holders of record at the close of business on December 18, 2017

  December 8, 2017

   · 

  2 min read
• Biotech Bay

  Rigel to Present One-Year Efficacy and Safety Results for Fostamatinib in ITP at the 2017 ASH Annual Meeting

  Rigel Pharma today announced that the one-year efficacy and safety results from its FIT Phase 3 clinical program of fostamatinib for chronic or persistent immune thrombocytopenia (ITP) will be featured in an oral presentation at the 2017 ASH Annual Meeting.

  December 8, 2017

   · 

  4 min read
• Pharm Country

  New Dental Material Resists Plaque and Kills Microbes, Penn Dental Medicine Team Finds

  In a new study, researchers from Penn Dental Medicine evaluated a new dental material tethered with an antimicrobial compound that can not only kill bacteria but can also resist biofilm growth.

  December 8, 2017

   · 

  2 min read
• ASIT biotech Shareholders Meeting Has Approved the Structure of the Next Financing Round

  The first warrant will expire on June 30, 2018, and the second on December 31, 2019.

  December 8, 2017

   · 

  1 min read
• Drug Development

  Flexion Therapeutics Enrolls First Patient in Phase II Pharmacokinetics and Safety Study of ZILRETTA (Triamcinolone Acetonide Extended-Release Injectable Suspension) in Bilateral Osteoarthritis of the Knee

  The randomized, open-label, Phase 2 study is expected to enroll approximately 24 patients.

  December 8, 2017

   · 

  6 min read
• 

  Drug Development

  Pfizer Shows Off Phase III Breast Cancer Data

  The data will be presented today as an oral presentation at the 2017 San Antonio Breast Cancer Symposium.

  December 8, 2017

   · 

  10 min read